000 01396 a2200421 4500
005 20250517235250.0
264 0 _c20190213
008 201902s 0 0 eng d
022 _a1879-0712
024 7 _a10.1016/j.ejphar.2018.09.003
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aRinne, Maiju K
245 0 0 _aPharmacological characterization of the orexin/hypocretin receptor agonist Nag 26.
_h[electronic resource]
260 _bEuropean journal of pharmacology
_cOct 2018
300 _a137-144 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAdenylyl Cyclases
_xmetabolism
650 0 4 _aAnimals
650 0 4 _aBenzamides
_xchemistry
650 0 4 _aCHO Cells
650 0 4 _aCalcium
_xmetabolism
650 0 4 _aCricetulus
650 0 4 _aHumans
650 0 4 _aOrexin Receptors
_xagonists
650 0 4 _aOrexins
_xpharmacology
650 0 4 _aSolubility
650 0 4 _aType C Phospholipases
_xmetabolism
650 0 4 _aets-Domain Protein Elk-1
_xphysiology
700 1 _aLeino, Teppo O
700 1 _aTurku, Ainoleena
700 1 _aTurunen, Pauli M
700 1 _aSteynen, Yana
700 1 _aXhaard, Henri
700 1 _aWallén, Erik A A
700 1 _aKukkonen, Jyrki P
773 0 _tEuropean journal of pharmacology
_gvol. 837
_gp. 137-144
856 4 0 _uhttps://doi.org/10.1016/j.ejphar.2018.09.003
_zAvailable from publisher's website
999 _c28815565
_d28815565